|

PF-07248144 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • Pfizer2

Indications

  • Breast Cancer2
  • Cancer2
  • Locally Advanced or Metastatic Castration-resistant Prostate Cancer1
  • Locally Advanced or Metastatic ER+ HER2- Breast Cancer1
  • Locally Advanced or Metastatic Non-small Cell Lung Cancer1

Chandler, Arizona1 trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Ironwood Cancer & Research Centers

Phase 3

Scottsdale, Arizona1 trial

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

HonorHealth

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.